|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US4036842A
(en)
|
1972-05-16 |
1977-07-19 |
American Home Products Corporation |
Process for preparing polycyclic heterocycles having a pyran ring
|
|
US4021451A
(en)
|
1972-05-16 |
1977-05-03 |
American Home Products Corporation |
Process for preparing polycyclic heterocycles having a pyran ring
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4021452A
(en)
|
1975-04-23 |
1977-05-03 |
American Cyanamid Company |
2,5-Dihydro-2,5-dialkoxyfuran derivatives
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4127665A
(en)
|
1978-01-18 |
1978-11-28 |
Pfizer Inc. |
Thienohydantoin derivatives
|
|
FR2459239A1
(fr)
|
1979-06-20 |
1981-01-09 |
Logeais Labor Jacques |
Nouveaux derives amines du benzothiazole, leur procede de preparation et leur application en therapeutique
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
PH30676A
(en)
|
1986-07-22 |
1997-09-16 |
Boehringer Ingelhein Kg |
Hetrazepine compounds which have useful pharmaceutical utility
|
|
IE67334B1
(en)
|
1988-03-16 |
1996-03-20 |
Smithkline Beecham Farma |
Heterocyclic derivatives
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
DE3827727A1
(de)
|
1988-08-16 |
1990-02-22 |
Boehringer Ingelheim Kg |
Anellierte tetrahydropyridinessigsaeurederivate, verfahren zu deren herstellung und verwendung solcher verbindungen zur kardioprotektion
|
|
GB8824400D0
(en)
|
1988-10-18 |
1988-11-23 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP0368175A1
(de)
|
1988-11-06 |
1990-05-16 |
Boehringer Ingelheim Kg |
3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.
|
|
GB8827479D0
(en)
|
1988-11-24 |
1988-12-29 |
Zambeletti Spa L |
Novel compounds
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
EP0416740A3
(en)
|
1989-08-08 |
1991-08-28 |
Beecham Group P.L.C. |
Novel compounds with renin-inhibiting activity
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
GB8926560D0
(en)
|
1989-11-24 |
1990-01-17 |
Zambeletti Spa L |
Pharmaceuticals
|
|
GB8927872D0
(en)
|
1989-12-08 |
1990-02-14 |
Beecham Group Plc |
Pharmaceuticals
|
|
US5032598A
(en)
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
ZA912744B
(en)
|
1990-03-23 |
1992-02-26 |
Zambeletti Spa L |
Pharmaceuticals
|
|
JPH049367A
(ja)
|
1990-04-26 |
1992-01-14 |
Zeria Pharmaceut Co Ltd |
アリールアルカノイル誘導体，該化合物の製造中間体及びそれらを含有する医薬
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
GB9018139D0
(en)
|
1990-08-17 |
1990-10-03 |
Pfizer Ltd |
Therapeutic agents
|
|
NZ240155A
(en)
|
1990-10-29 |
1992-10-28 |
Ishihara Sangyo Kaisha |
Heterocyclyl acyl and (hexahydro) indanyl acyl substituted hydrazine derivatives, preparation thereof and pesticidal compositions
|
|
DE4104257A1
(de)
|
1991-02-13 |
1992-08-20 |
Boehringer Ingelheim Kg |
Verwendung von anellierten tetrahydropyridinessigsaeurederivaten fuer die behandlung neurologischer erkrankungen
|
|
GB9104839D0
(en)
|
1991-03-07 |
1991-04-17 |
Zambeletti Spa L |
Novel compounds
|
|
NZ243065A
(en)
|
1991-06-13 |
1995-07-26 |
Lundbeck & Co As H |
Piperidine derivatives and pharmaceutical compositions
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
PH31294A
(en)
|
1992-02-13 |
1998-07-06 |
Thomae Gmbh Dr K |
Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them.
|
|
JP3223277B2
(ja)
|
1992-04-10 |
2001-10-29 |
カシオ計算機株式会社 |
楽音制御装置
|
|
FR2692264B1
(fr)
|
1992-06-12 |
1994-08-05 |
Adir |
Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
|
|
IT1255178B
(it)
|
1992-06-26 |
1995-10-20 |
Pierrel Spa |
N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica
|
|
EP0600836B1
(de)
|
1992-12-02 |
1998-08-05 |
Novartis AG |
Selektiv-herbizides Mittel
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
TW334423B
(en)
|
1993-10-22 |
1998-06-21 |
Hoffmann La Roche |
Tricyclic 1-aminoethylpyrrole-derivatives
|
|
JP3163068B2
(ja)
|
1993-12-27 |
2001-05-08 |
日本建工株式会社 |
野縁取付け金具
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
FR2723091B1
(fr)
|
1994-07-29 |
1996-11-08 |
Esteve Labor Dr |
Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
|
|
FR2734819B1
(fr)
|
1995-05-31 |
1997-07-04 |
Adir |
Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
|
|
WO1999046237A1
(en)
|
1998-03-12 |
1999-09-16 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases
|
|
EP1080095B1
(en)
|
1998-03-12 |
2005-11-02 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (ptpases)
|
|
WO1999046267A1
(en)
|
1998-03-12 |
1999-09-16 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (ptpases)
|
|
US6262044B1
(en)
|
1998-03-12 |
2001-07-17 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (PTPASES)
|
|
EP1123292A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
ES2257089T3
(es)
|
1998-12-14 |
2006-07-16 |
Astellas Pharma Inc. |
Derivados de piperazina.
|
|
DE60028538T2
(de)
|
1999-01-19 |
2007-06-21 |
Neurosearch A/S |
Kondensierte heterocyclische verbindungen und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
|
|
US6313309B1
(en)
|
1999-04-05 |
2001-11-06 |
Ortho-Mcneil Pharmaceutical, Inc. |
4-thionaphthyl—1H—imidazoles which are usefulα22-adrenoceptoR agonists/ antagonists
|
|
AU4589800A
(en)
|
1999-05-05 |
2000-11-21 |
Darwin Discovery Limited |
9-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,9-dihydropurin-6-one derivatives as pde7inhibitors
|
|
US7019026B1
(en)
|
1999-09-10 |
2006-03-28 |
Novo Nordisk A/S |
Modulators of Protein Tyrosine Phosphatases (PTPases)
|
|
WO2001017516A2
(en)
|
1999-09-10 |
2001-03-15 |
Novo Nordisk A/S |
Method of inhibiting protein tyrosine phosphatase 1b and/or t-cell protein tyrosine phosphatase and/or other ptpases with an asp residue at position 48
|
|
AU7961200A
(en)
|
1999-10-29 |
2001-05-14 |
Kaken Pharmaceutical Co., Ltd. |
Urea derivative, process for producing the same, and medicine containing the urea derivative
|
|
AR030537A1
(es)
|
1999-11-05 |
2003-08-27 |
Abbott Lab |
Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos
|
|
US7112594B2
(en)
|
2000-08-09 |
2006-09-26 |
Mitsubishi Pharma Corporation |
Fused bicyclic amide compounds and medicinal use thereof
|
|
WO2002022614A1
(en)
|
2000-09-12 |
2002-03-21 |
Sankyo Company,Limited |
Quinolizine derivatives
|
|
WO2002102387A1
(en)
|
2001-06-18 |
2002-12-27 |
H. Lundbeck A/S |
Treatment of neuropathic pain
|
|
US20040180883A1
(en)
|
2001-07-11 |
2004-09-16 |
Jeremy Gilmore |
Pharmaceutical compounds with serotonin receptor activity
|
|
EP1409476B1
(en)
|
2001-07-11 |
2004-12-15 |
Eli Lilly And Company |
Pharmaceutical compounds with serotonin receptor activity
|
|
BR0213562A
(pt)
|
2001-10-26 |
2004-08-31 |
Aventis Pharma Inc |
Benzimidazóis e análogos e seu uso como inibidores de cinases de proteìna
|
|
JP2003261566A
(ja)
|
2002-03-11 |
2003-09-19 |
Sankyo Co Ltd |
キノリジンを含有する医薬
|
|
TW200306783A
(en)
|
2002-04-29 |
2003-12-01 |
Fmc Corp |
Pesticidal heterocycles
|
|
US7091232B2
(en)
|
2002-05-21 |
2006-08-15 |
Allergan, Inc. |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
|
|
US7358269B2
(en)
|
2002-05-21 |
2008-04-15 |
Allergan, Inc. |
2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one
|
|
US7276522B2
(en)
|
2002-05-21 |
2007-10-02 |
Allergan, Inc. |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
|
|
US7323485B2
(en)
|
2002-05-21 |
2008-01-29 |
Allergan, Inc. |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
|
|
SE0202134D0
(sv)
|
2002-07-08 |
2002-07-08 |
Astrazeneca Ab |
Therapeutic agents
|
|
EP1554394B1
(en)
|
2002-10-16 |
2009-12-16 |
Isis Innovation Limited |
Screening methods using a structural model of FIH
|
|
WO2004066912A2
(en)
|
2003-01-31 |
2004-08-12 |
Technion Research & Development Foundation Ltd. |
Anti-inflammatory compositions and uses thereof
|
|
EP2527326B1
(en)
|
2003-03-07 |
2014-10-08 |
Santen Pharmaceutical Co., Ltd |
Novel compounds having 4-pyridylalkylthio group as substituent
|
|
JP2004269449A
(ja)
|
2003-03-11 |
2004-09-30 |
Ishihara Sangyo Kaisha Ltd |
ベンズアミド誘導体、それらの製造方法及びそれらを含有する有害生物防除剤
|
|
WO2004080476A1
(en)
*
|
2003-03-12 |
2004-09-23 |
University Of North Carolina At Chapel Hill |
Use of secretin in the treatment of schizophrenia
|
|
US7205318B2
(en)
|
2003-03-18 |
2007-04-17 |
Bristol-Myers Squibb Company |
Lactam-containing cyclic diamines and derivatives as a factor Xa inhibitors
|
|
US20070010671A1
(en)
|
2003-03-31 |
2007-01-11 |
Yoshinori Sekiguchi |
Novel quinazoline derivatives and methods of treatment related to the use thereof
|
|
JP2005145859A
(ja)
|
2003-11-13 |
2005-06-09 |
Nippon Steel Chem Co Ltd |
脱水素化方法及び芳香族複素環化合物の製造方法
|
|
DE10360793A1
(de)
|
2003-12-23 |
2005-07-28 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
AU2005208938A1
(en)
|
2004-01-29 |
2005-08-11 |
Elixir Pharmaceuticals, Inc |
Anti-viral therapeutics
|
|
DE102004004974A1
(de)
|
2004-01-31 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen
|
|
KR100553398B1
(ko)
|
2004-03-12 |
2006-02-16 |
한미약품 주식회사 |
티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
|
|
WO2006015259A2
(en)
|
2004-07-28 |
2006-02-09 |
Irm Llc |
Compounds and compositions as modulators of steroid hormone nuclear receptors
|
|
SE0401970D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Novel compounds
|
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
|
EP1634873A1
(en)
|
2004-08-27 |
2006-03-15 |
Laboratorios Del Dr. Esteve, S.A. |
Sigma receptor inhibitors
|
|
FR2875230A1
(fr)
|
2004-09-13 |
2006-03-17 |
Sanofi Aventis Sa |
Derives de pyrazole condense, leur preparation et leur application en therapeutique
|
|
JP2006117568A
(ja)
|
2004-10-20 |
2006-05-11 |
Mitsubishi Pharma Corp |
チオフェン環を有する新規アミド誘導体及びその医薬としての用途
|
|
WO2006053274A2
(en)
|
2004-11-15 |
2006-05-18 |
Bristol-Myers Squibb Company |
2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
|
|
US7297704B2
(en)
|
2005-02-17 |
2007-11-20 |
Wyeth |
Cycloalkyfused indole, benzothiophene, benzofuran and idene derivatives
|
|
AU2006240789B2
(en)
|
2005-04-22 |
2010-03-04 |
Daiichi Sankyo Company, Limited |
Heterocyclic compound
|
|
WO2007001939A1
(en)
|
2005-06-27 |
2007-01-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities
|
|
EP1896515A4
(en)
|
2005-06-27 |
2010-03-10 |
Du Pont |
ELECTRICALLY CONDUCTIVE POLYMER COMPOSITIONS
|
|
JP2009505948A
(ja)
|
2005-07-11 |
2009-02-12 |
デブジェン エヌブイ |
キナーゼ阻害剤としてのアミド誘導体
|
|
WO2007095586A2
(en)
|
2006-02-14 |
2007-08-23 |
The Trustees Of Columbia University In The City Of New York |
Neuronal pain pathway modulators
|
|
AU2007222069A1
(en)
|
2006-02-21 |
2007-09-13 |
Ampla Pharmaceuticals Inc. |
CB1 antagonists and inverse agonists
|
|
EP1829869A1
(en)
|
2006-03-02 |
2007-09-05 |
Laboratorios Del Dr. Esteve, S.A. |
4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
|
|
AR059898A1
(es)
*
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
WO2007126041A1
(ja)
|
2006-04-28 |
2007-11-08 |
Eisai R & D Management Co., Ltd. |
ベンゾイソオキサゾール化合物
|
|
WO2008034087A2
(en)
*
|
2006-09-15 |
2008-03-20 |
Xenoport, Inc. |
Treating schizophrenia with combinations of levodopa and an antipsychotic agent
|
|
KR20090074219A
(ko)
|
2006-10-04 |
2009-07-06 |
쉐링 코포레이션 |
트롬빈 수용체 길항제로서의 비사이클릭 및 트리사이클릭 유도체
|
|
US7960569B2
(en)
|
2006-10-17 |
2011-06-14 |
Bristol-Myers Squibb Company |
Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
|
|
AU2007321720A1
(en)
|
2006-11-15 |
2008-05-22 |
Genetic Technologies Limited |
Compounds, compositions and methods for controlling invertebrate pests
|
|
WO2009008906A2
(en)
|
2007-02-06 |
2009-01-15 |
The Trustees Of The University Of Pennsylvania |
Therapeutic compounds for blocking dna synthesis of pox viruses
|
|
US7598417B2
(en)
|
2007-04-12 |
2009-10-06 |
Allergan, Inc. |
Substituted fluoroethyl ureas as alpha 2 adrenergic agents
|
|
EP1982987A1
(en)
|
2007-04-16 |
2008-10-22 |
Laboratorios del Dr. Esteve S.A. |
Spiro-pyrano-pyrazole derivatives
|
|
EP1982714A1
(en)
|
2007-04-16 |
2008-10-22 |
Laboratorios del Dr. Esteve S.A. |
Pyrano-pyrazole-amines
|
|
EP2020414A1
(en)
|
2007-06-20 |
2009-02-04 |
Laboratorios del Dr. Esteve S.A. |
spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis
|
|
US8338623B2
(en)
|
2007-07-09 |
2012-12-25 |
Abbvie Inc. |
Compounds as cannabinoid receptor ligands
|
|
US8158792B2
(en)
|
2007-11-21 |
2012-04-17 |
Janssen Pharmaceutica N.V. |
Spiropiperidines for use as tryptase inhibitors
|
|
US7973051B2
(en)
|
2007-11-30 |
2011-07-05 |
Hoffman-La Roche Inc. |
Aminothiazoles as FBPase inhibitors for diabetes
|
|
JPWO2009072621A1
(ja)
|
2007-12-07 |
2011-04-28 |
日産化学工業株式会社 |
置換ジヒドロアゾール化合物及び有害生物防除剤
|
|
WO2009085256A1
(en)
|
2007-12-27 |
2009-07-09 |
Panacos Pharmaceuticals, Inc. |
Anti-hiv compounds
|
|
CN101759710B
(zh)
|
2008-10-06 |
2011-10-05 |
山东轩竹医药科技有限公司 |
含有取代的氮杂环的头孢菌素衍生物
|
|
WO2010053583A2
(en)
|
2008-11-10 |
2010-05-14 |
Dana Farber Cancer Institute |
Small molecule cd4 mimetics and uses thereof
|
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
|
WO2011036889A1
(ja)
|
2009-09-25 |
2011-03-31 |
武田薬品工業株式会社 |
複素環化合物
|
|
UA107943C2
(xx)
|
2009-11-16 |
2015-03-10 |
Lilly Co Eli |
Сполуки спіропіперидину як антагоністи рецептора orl-1
|
|
JP5723381B2
(ja)
|
2009-11-16 |
2015-05-27 |
イーライ リリー アンド カンパニー |
Ｏｒｌ−１受容体アンタゴニストとしてのスピロピペリジン化合物
|
|
WO2011069063A2
(en)
|
2009-12-04 |
2011-06-09 |
Sunovion Pharmaceuticals, Inc. |
Multicyclic compounds and methods of use thereof
|
|
JP5794922B2
(ja)
|
2009-12-28 |
2015-10-14 |
一般社団法人ファルマバレープロジェクト支援機構 |
１，３，４−オキサジアゾール−２−カルボキサミド化合物
|
|
EP2377850A1
(en)
|
2010-03-30 |
2011-10-19 |
Pharmeste S.r.l. |
TRPV1 vanilloid receptor antagonists with a bicyclic portion
|
|
JP2013525368A
(ja)
|
2010-04-23 |
2013-06-20 |
キネタ・インコーポレイテツド |
抗ウイルス性化合物
|
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
WO2012122340A1
(en)
|
2011-03-10 |
2012-09-13 |
Boehringer Ingelheim International Gmbh |
Soluble guanylate cyclase activators
|
|
CN102731574B
(zh)
|
2011-03-30 |
2016-03-02 |
中国人民解放军军事医学科学院毒物药物研究所 |
噻吩并吡啶类α-胺基苄基膦酸酯、其制备方法及用途
|
|
WO2013010453A1
(en)
|
2011-07-15 |
2013-01-24 |
Abbott Laboratories |
Chemoking receptor antagonists
|
|
JP6333382B2
(ja)
|
2014-07-23 |
2018-05-30 |
シャープ株式会社 |
表示装置およびその駆動方法
|
|
WO2018151861A1
(en)
*
|
2017-02-16 |
2018-08-23 |
Sunovion Pharamaceuticials Inc. |
Methods of treating schizophrenia
|
|
US20210008030A1
(en)
|
2018-02-16 |
2021-01-14 |
Sunovion Pharmaceuticals Inc. |
Methods of treating social function disorders
|
|
CA3091292A1
(en)
|
2018-02-16 |
2019-08-22 |
Sunovion Pharmaceuticals Inc. |
Salts, crystal forms, and production methods thereof
|
|
AU2019394956B2
(en)
|
2018-12-06 |
2025-05-08 |
Sunovion Pharmaceuticals Inc. |
Methods of treating neurological and psychiatric disorders
|